start portlet menu bar end portlet menu bar

Efficacy of UBAC® vaccine against an experimental intramammary heterologous challenge in dairy heifers (bacterial count, scc and serological response)

Strona główna Wiedza Efficacy of UBAC® vaccine against an experimental intramammary heterologous challenge in dairy heifers (bacterial count, scc and serological response)

Efficacy of UBAC® vaccine against an experimental intramammary heterologous challenge in dairy heifers (bacterial count, scc and serological response)

The aim of this study is evaluate the efcacy of a new S . uberis vaccine against bovine mastitis (UBAC®, HIPRA S.A, Spain) after an experimental intramammary challenge with a heterologous S . uberis strain (SU2H) in dairy heifers.

Pobierz ten artykuł

140 kB

O tym artykule

Opublikowano w

National Mastitis Council, 2018

Data

11.06.2018

Autorzy

Montbrau, C.; Collado, R.; Prenafeta, A.; March, R.; Moreno, J.

Streszczenie

The results presented in this study demonstrate that the intramuscular immunization of dairy heifers with UBAC® vaccine signicantly reduces the bacteriological count and SCC, increasing the cure rate of the infected quarters after an intramammary infection with S . uberis heterologous strain.

Powiązane produkty

UBAC®

Powiązane publikacje

A diagnostic tool for the detection and quantification of pathogenic bacteria in bovine milk samples from dairy farms in South Korea Case Report: Field experience with a polyvalent mastitis vaccine on a commercial dairy farm infected with Klebsiella Mastitis pathogens detected in Europe using real-time multiplex PCR

Udostępnij na

start portlet menu bar

UBAC® vaccine against intramammary heterologous challenge in dairy heifers

Display portlet menu
end portlet menu bar

Patrz także

Publikacje

Serological response of calves vaccinated with 1 dose of a gE-/tk- deleted MLV IBR

01-10-2018
Post

Udder Health by HIPRA and CowSignals: 1 + 1 = 3

12-05-2017
Aktualności

HIPRA's new Customer Portal

21-09-2018